Idiopathic thrombocytopenic purpura: Guidance amid uncertainty

Cleveland Clinic Journal of Medicine

Volumn 65, Issue 10, 1998, Pages 510-514

  Lichtin, Alan ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GLUCOCORTICOID; IMMUNOGLOBULIN G; RHESUS D ANTIBODY; THROMBOPOIETIN;

ARTICLE; BONE MARROW BIOPSY; DIAGNOSTIC APPROACH ROUTE; GENETIC ENGINEERING; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INTRAVENOUS DRUG ADMINISTRATION; PRACTICE GUIDELINE; SPLENECTOMY; SURGICAL APPROACH; THROMBOCYTE COUNT; TREATMENT PLANNING;

EID: 0032457025     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.65.10.510     Document Type: Article

References (7)

1. George JN, Woolf SH, Raskob GE, et al. Idiopathic thrombocytopenic purpura. A practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996; 88:3-40.
2. The American Society of Hematology ITP Practice Guideline Panel. Diagnosis and treatment of idiopathic thrombocytopenic purpura: Recommendations of the American Society of Hematology. Ann Intern Med 1997; 126:319-326.
3. George JN, El-Harake MA, Raskob GE. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1994; 331:1207-1211.
4. McMillan R. Therapy for adults with refractory chronic ITP. Ann Intern Med 1997; 126:307-314.
5. Kaushanksy K. Thrombopoietin. N Engl J Med 1998; 339:746-754.
6. Mohn C, Shi Y, Laman, JD, et al. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 1995; 154:1470-1480.
7. Andrew M, Blanchette VS, Barnard D, et al. A multicenter study of the treatment of childhood ITP with anti-D. J Pediatr 1992: 120:522-527.